Claudette D. Brooks

FDA investigator · also recorded as D. Brooks

Appears on 6 documents from 2003 to 2018, mostly at sites in North Carolina. Most often cites production and process controls (21 CFR 820.70).

6
Documents on file
10.2
Observations per 483
2003
First seen
2018
Most recent

What they cite most

From 59 observations

Activity by year

2003: 1, 2006: 1, 2011: 1, 2015: 2, 2018: 1

Where

North Carolina 3 · Georgia 2 · South Carolina 1

Is Claudette D. Brooks coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

6 documents, newest first
FirmOpen
483 Hospira, Inc.Feb 2, 2018 · Rocky Mount, North Carolina
483 Hospira, A Pfizer CompanySep 24, 2015 · Rocky Mount, North Carolina
Amended 483 St Jude MedicalJul 6, 2015 · Atlanta, Georgia
483 Hospira Inc.Jun 17, 2011 · Rocky Mount, North Carolina
483 Bausch & Lomb Inc.May 15, 2006 · Greenville, South Carolina
483 CryoLife, Inc.Feb 14, 2003 · Kennesaw, Georgia

About this profile

What does Claudette D. Brooks inspect?

Claudette D. Brooks appears on 6 documents on file covering 4 sites, mostly in North Carolina.

What do they cite most often?

21 CFR 820.70 (production and process controls), followed by 21 CFR 820.30 and 21 CFR 820.100.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Claudette D. Brooks is dated Feb 2, 2018.